2019
DOI: 10.1016/j.neulet.2018.12.017
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of acute transcranial direct current stimulation on non-motor and motor symptoms in Parkinson’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
44
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 34 publications
(44 citation statements)
references
References 34 publications
0
44
0
Order By: Relevance
“…The stimulation facilitates or inhibits spontaneous neuronal activity putatively resulting in cortical excitability modulation [47] and neuroplastic reorganization [811]. tDCS has been used in neuropsychiatric [1214] and neurological disorders [1519], modulation of autonomic nervous system [2023], appetite [2426], energy expenditure [27], motor performance [21, 28, 29] and motor learning [8, 3033]. More recently, a high-definition-tDCS (HD-tDCS) was developed with arrays of smaller “high-definition” electrodes to increase brain modulation accuracy [34, 35].…”
Section: Introductionmentioning
confidence: 99%
“…The stimulation facilitates or inhibits spontaneous neuronal activity putatively resulting in cortical excitability modulation [47] and neuroplastic reorganization [811]. tDCS has been used in neuropsychiatric [1214] and neurological disorders [1519], modulation of autonomic nervous system [2023], appetite [2426], energy expenditure [27], motor performance [21, 28, 29] and motor learning [8, 3033]. More recently, a high-definition-tDCS (HD-tDCS) was developed with arrays of smaller “high-definition” electrodes to increase brain modulation accuracy [34, 35].…”
Section: Introductionmentioning
confidence: 99%
“…Nitsche & Paulus, 2000). This predictability has led to recent investigation into tDCS application in pathological population including Parkinson's disease (Broeder et al, 2019;Bueno et al, 2019), epilepsy (Lin et al, 2018;Tecchio et al, 2018) stroke rehabilitation (Biou et al, 2019;Solomons & Shanmugasundaram, 2019), cerebral palsy (Inguaggiato et al, 2019), chronic pain (Callai et al, 2019;Jafarzadeh et al, 2019), depression (Aparicio et al, 2019) and cognitive impairment (Emonson et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…One study tested in both off and on dopaminergic medication [ 33 ], one tested in the off state [ 49 ], and one did not report medication status [ 52 ]. Five investigations had open-label designs [ 38 , 43 , 45 , 46 , 47 ]; seven were parallel arm, randomized, double-blind, sham-controlled designs [ 33 , 40 , 41 , 42 , 44 , 50 , 52 ]; and eight were crossover, randomized, sham-controlled designs, with six being double-blind [ 36 , 37 , 39 , 48 , 49 , 51 ] and two with unstated blinding [ 34 , 35 ]. The tDCS intensities ranged from 1 to 2.8 mA (range of current densities = 0.02 mA/cm 2 –0.12 mA/cm 2 ) and stimulation was applied for 7–30 min (mode = 20 min).…”
Section: Resultsmentioning
confidence: 99%